- Cronos Group Unveils New CBG Product, SPINACH FEELZ ™ Chill Bliss 2: 1 THC | Gummy CBG, Made Using Proprietary Fermentation Methods To Produce CBG Without Using The Cannabis Plant
- FEELZ ™ SPINACH the platform’s latest innovation, the Chill Bliss gum, is a one-of-a-kind CBG product containing THC and tropical terpenes, now available on the Canadian market
- The new Spinach ™ brand platform, SPINACH FEELZ ™, plans to produce a full line of cannabis products containing THC and rare cannabinoids in a wide range of product formats to enable unique experiences for consumers.
TORONTO, Oct. 20, 2021 (GLOBE NEWSWIRE) – Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) is pleased to announce the launch of its SPINACH FEELZ ™ Chill Gummy Bliss 2: 1 THC | CBG, the first edible cannabis of its kind in Canada to contain THC and cultured cannabigerol (“CBG”) from fermentation in a sweet and delicious gummy for adult consumers. As the only cannabis gum in Canada to contain cultured CBG, one of many rare cannabinoids found in small amounts in the cannabis plant, this gum is formulated to provide a happy and relaxed experience.
SPINACH FEELZ ™ Chill Bliss 2: 1 THC | CBG gummies come in a pineapple star fruit flavor and feature the same combination of dual flavors and flavor masking technology that made SOURZ ™ gummies the one of the best selling cannabis edibles in Canada.
SPINACH FEELZ ™ Chill Bliss 2: 1 THC | CBG gummies are now available in the following format in Alberta, British Columbia, Manitoba, Ontario and Saskatchewan.
- Pineapple Starfruit – (2: 1 THC | CBG)
- 10 mg of THC and 5 mg of CBG per pack
- Each pack contains 2 gummy candies
“Today we mark an incredible achievement for Cronos Group and the cannabis industry as a whole with the launch of the first edible cannabis in Canada containing cultured CBG. This new product is truly a breakthrough in cannabis innovation, ”said Kurt Schmidt, President and CEO, Cronos Group. “We are achieving our ultimate goal of introducing exceptional products that will unleash the full potential of cannabis and we look forward to bringing more rare cannabinoids to the market under the SPINACH FEELZ ™ sub-brand. “
The revolutionary new platform and sub-brand of the Spinach ™ brand, SPINACH FEELZ ™, plans to produce a full line of cannabis products, which will highlight rare cannabinoids in a wide range of product formats, designed to deliver unique and enhanced experiences made possible by proprietary blends of rare cannabinoids alongside more common cannabinoids like THC and CBD. Each product will be formulated to help adult consumers, “Feelz. The way you want. “
SPINACH FEELZ ™ Chill Bliss gum is the Cronos Group’s first consumer product created through the Company’s partnership with Ginkgo Bioworks (“Ginkgo”). Cronos Group and Ginkgo recently announced the achievement of the first target productivity milestone in this partnership, with CBG being the first cultured cannabinoid to be successfully produced on a commercial scale.
For more information and availability, please visit https://spinachcannabis.com/edibles.
About the Cronos group
Cronos Group is an innovative global cannabinoid company with international production and distribution on five continents. Cronos Group is committed to creating disruptive intellectual property by advancing cannabis research, technology and product development. With a passion for responsibly elevating the consumer experience, Cronos Group is building a portfolio of iconic brands. The portfolio of the Cronos group includesNATURAL PEACE™, a global wellness platform, two brands for adult use,CREEK™ andSpinach™, and three brands of CBD derived from American hemp,Lord Jones™,Happy dance™ andPEACE +™. For more information on Cronos Group and its brands, please visit:thecronosgroup.com.
This press release may contain information that may constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable Canadian and US securities laws (collectively, “forward-looking statements”). All information contained in this document which is not clearly historical in nature may constitute forward-looking statements. In some cases, forward-looking statements may be identified by the use of forward-looking terms such as “may”, “will”, “expect”, “plan”, “anticipate”, “intend”, “Possible”, “” estimate ”,“ believe ”or the negative of these terms, or other similar expressions intended to identify forward-looking statements. Some of the forward-looking statements contained in this press release include the Company’s objective to introduce exceptional products that will unlock the full potential of cannabis and its intention to market rarer cannabinoid products; the Company’s intention to produce a full line of cannabis products featuring rare cannabinoids in a wide range of product formats; the Company’s expectations regarding the potential success and the costs and benefits associated with its partnership with Ginkgo; the Company’s intention to build a portfolio of iconic international brands and develop disruptive intellectual property. Forward-looking statements are necessarily based on a number of estimates and assumptions which, although considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, earnings, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements and statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020, the Company’s Quarterly Report on Form 10-Q for the period closed on March 31. 2021 and the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2021, each of which has been filed on SEDAR and EDGAR and can be viewed at www.sedar.com and www.sec.gov / edgar, respectively. Any forward-looking statement included in this press release is made as of the date of this press release and, except as required by law, Cronos Group disclaims any obligation to update or revise any forward-looking statement. Readers are cautioned not to place undue reliance on a forward-looking statement.
For more information, please contact:
Contact person for media relations:
Phone. : (416) 504-0004
Investor Relations Contact:
Phone. : (416) 504-0004
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d640105f-66ad-4479-9ded-0d777b101742